This also resulted in a significantly shorter terminal elimination half-life after the higher, 150-mg dose ( P = 0.024) but did not reach statistical significance in the lower, 75-mg dose group ( P = 0.56).
← all excerpts
Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
1
0.5600
0.5600